Coronavirus COVID-19 Vaccine Update: Latest Developments – Pfizer

Pfizer has a longstanding commitment to ensure that access to study- and participant-level clinical trial data is available to regulators, researchers, and trial participants. We seek to provide as much data transparency as possible without jeopardizing the regulatory decision- making process, participant privacy, or intellectual property and have a process in place for data requests, utilizing an independent platform called Vivli.

We are participating in the International COVID-19 Data Alliance (ICODA) as well as TransCelerate BioPharma consortium to share study- and participant-level clinical data from our COVID-19 trials at the appropriate times after regulatory submissions.

For more information on our data sharing policies and to request data from the COVID-19 vaccine trials, please visit our Data Request page.

Visit link:

Coronavirus COVID-19 Vaccine Update: Latest Developments - Pfizer